URSODEOXYCHOLIC ACID
ursodiol
128-13-2
Actigall
UDCA
Ursodesoxycholic acid
Urso Forte
Deursil
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
Acido ursodeoxicolico
Urso 250
Ursonorm
Acidum ursodeoxycholicum
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
CHEBI:9907
acide ursodeoxycholique
DTXSID6023731
724L30Y2QR
NSC-683769
Ursacholic Acid
Deoxyursocholic Acid
Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-
3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid
Acid, Ursacholic
Acid, Deoxyursocholic
Acid, Ursodeoxycholic
Ursodeoxycholate, Sodium
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
Cholurso
Usodiol
NSC657950
NSC683769
(4R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoic acid
Ursodiol 200 mg
Ursodiol 400 mg
Reltone 200 mg
Reltone 400 mg
URUSA
acido ursodesossicolico
acidum ursodesoxycholicum
RefChem:56193
DTXCID003731
Ursodeoxycholic Acid (Ursodiol)
A05AA02
204-879-3
ursodeoxycholate
Ursofalk
Ursolvan
UrSO
Delursan
Destolit
Ursochol
Cholit-ursan
Litursol
Solutrat
Ursobilin
Ursodamor
Arsacol
Lyeton
Ursacol
Urso DS
Ursosan
3-alpha,7-beta-Dioxycholanic acid
Ursocholic acid, deoxy-
Ursodeoxycholicacid
3-alpha,7-beta-Dihydroxycholanic acid
MFCD00003680
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
NSC 683769
Peptarom
Ursodeoxycholic acid [INN]
CHEMBL1551
MLS000028461
Ursodiol [USAN]
Antigall
SMR000058403
Urosiol
Cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)-
7-beta-Hydroxylithocholic acid
Ursodexycholic Acid
Acido ursodeossicolico [Italian]
Acido ursodeossicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum [INN-Latin]
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
7beta-Hydroxylithocholic acid
Actigall (TN)
Ursodiol (USP)
CCRIS 5502
Urso (TN)
SR-01000737091
Ursodiol [USAN:USP]
IU5
EINECS 204-879-3
NSC 657950
5beta-Cholanic Acid-3alpha,7beta-diol
BRN 3219888
Ursodexycholate
Paptarom
Udiliv
Ursodesoxycholic acid (UDCA)
Desol
Urdes
UNII-724L30Y2QR
Urosdesoxycholate
5beta-Cholan-24-oic acid-3alpha,7beta-diol
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
Ursodeoxycholoc acid
Urosdesoxycholic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
URSODIOL [MI]
Ursodiol (Actigal Urso)
URSODIOL [VANDF]
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
U0030
7A-Hydroxylithocholic acid
URSODIOL [USP-RS]
EC 204-879-3
SCHEMBL27200
BSPBio_000956
4-10-00-01604 (Beilstein Handbook Reference)
cid_31401
MLS001066373
MLS002548885
SPBio_003105
Ursodeoxycholic acid, >=99%
URSODIOL [ORANGE BOOK]
BPBio1_001052
GTPL7104
7.beta.-Hydroxylithocholic acid
5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy-
URSODIOL [USP MONOGRAPH]
BDBM53721
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
GLXC-06706
HMS1570P18
HMS2097P18
HMS2233L14
HMS3259A13
HMS3714P18
Ursodeoxycholic acid (JP18/INN)
URSODEOXYCHOLIC ACID [JAN]
3alpha,7beta-dihydroxycholanic acid
MSK10386
3a,7b-dihydroxy-5b-cholan-24-oate
HB4645
LMST04010033
s1643
URSODEOXYCHOLIC ACID [MART.]
URSODEOXYCHOLIC ACID [WHO-DD]
5A-Cholan-24-oic acid-3A,7A-diol
AKOS015955898
CCG-220958
CS-1932
DB01586
FU09676
KS-5243
NC00487
SMP2_000012
3.alpha.,7.beta.-Dihydroxycholanic acid
3A,7A-Dihydroxy-5A-holan-24-oic acid
3a,7b-dihydroxy-5b-cholan-24-oic acid
NCGC00179363-01
NCGC00179363-12
(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
AC-18919
CAS#128-13-2
CPD000058403
HY-13771
NCI60_028904
URSODEOXYCHOLIC ACID [EP IMPURITY]
URSODEOXYCHOLIC ACID [EP MONOGRAPH]
AB00513977
NS00003715
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
3alpha, 7beta-dihydroxy-5beta-cholanoic acid
C07880
D00734
EN300-373707
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
AB00513977-09
AB00513977_10
F095820
Q241374
3.alpha.,7.beta.-Dihydroxy-5.beta.-cholanic acid
SR-01000737091-3
SR-01000737091-4
BRD-K15697815-001-15-4
BRD-K15697815-001-16-2
UDCA;Ursodiol;3a,7b-Dihydroxy-5b-cholan-24-oic acid
3.alpha.,7.beta.-Dihydroxy-5.beta.-cholan-24-oic acid
Z2588039022
3.ALPHA.,7.BETA.-DIHYDROXY-5B-CHOLAN-24-OIC ACID
5.beta.-Cholan-24-oic acid, 3.alpha.,7.beta.-dihydroxy-
Ursodiol, United States Pharmacopeia (USP) Reference Standard
Ursodeoxycholic acid, British Pharmacopoeia (BP) Reference Standard
Ursodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
17.beta.-(1-Methyl-3-carboxypropyl)etiocholane-3.alpha.,7.beta.-diol
3,7-Dihydroxycholan-24-oic acid-, (3.alpha.,5.beta.,7.beta.)- #
Ursodeoxycholic acid, 500 mug/mL in methanol, certified reference material
Ursodiol, Pharmaceutical Secondary Standard; Certified Reference Material
Ursodeoxycholic acid for system suitability, European Pharmacopoeia (EP) Reference Standard
(4R)-4-[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)-4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoicacid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid
108609-27-4
Solubility Characteristics
The compound (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid has a complex structure that significantly influences its solubility properties. When examining solubility, it's important to consider several factors:
As a result, it is expected that this compound exhibits:
In summary, the solubility of (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is likely to be significantly influenced by both its polar and non-polar regions, making it crucial to consider the solvent choice in experimental applications. Understanding these characteristics ensures the compound is effectively utilized in its respective fields.